Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19
Study sponsor: Invivyd, Inc. · IVVD
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-02-10Actual
Enrollment · participants399Actual
Source updated2024-02-06Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.